Form D · Pharmaceuticals
TORIGEN PHARMACEUTICALS, INC.
Farmington, CT · CIK 0001764961
Offering snapshot reported May 24, 2022 · SEC filing
- Reported sold
- $4.6M Offering amount: $10M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 9, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 24, 2022 | Initial | $4,601,438 | No comparison | 30 | SEC filing |
| Dec 6, 2021 | Initial | $1,223,912 | No comparison | 16 | SEC filing |
| Mar 5, 2021 | Amendment | $3,272,000 | $2,659,000vs Jun 16, 2020 | 38 | SEC filing |
| Jun 16, 2020 | Initial | $613,000 | No comparison | 10 | SEC filing |
| Jan 16, 2019 | Initial | $1,760,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-446858
Source: Form D, filed May 24, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin Crowley | Director |
| Terry Dew | Executive |
| Musan Duric | Director |
| Elizabeth Galbut | Director |
| Blake Hawley | Director |
| Ashley Kalinauskas | Director, Executive |
| John Kallassy | Executive |
| Brad Poff | Executive |
| Mark Suckow | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
400 Farmington Ave., R1855 Cb129
Farmington, CT, 06032
Farmington, CT, 06032